Bain Capital agrees to acquire UK vitamin maker Vitabiotics

• Bain Capital agreed to acquire Vitabiotics, the UK’s largest vitamin company, including its UK business and the wider VB Group.
• The deal targets faster international expansion across Vitabiotics’ footprint of more than 70 countries, with emphasis on MENA, India, and China.
• Operations are expected to continue without immediate day-to-day changes, with planned investment in e-commerce, distribution, supply chain, and product development.
• Vitabiotics founder Professor Kartar Lalvani is set to become chairman emeritus on completion; CEO Tej Lalvani will continue to lead.
• Closing remains subject to customary conditions, including regulatory approvals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bain Capital Private Equity LP published the original content used to generate this news brief on July 24, 2026, and is solely responsible for the information contained therein.